Eli Lilly and Company to Acquire Ajax Therapeutics to Expand Blood Cancer Pipeline
Eli Lilly and Company to acquire Ajax Therapeutics, advancing its blood cancer pipeline with AJ1-11095, a Phase 1 JAK2 inhibitor targeting myelofibrosis and polycythemia vera, with potential for improved disease control.
- Market | 28/04/2026 | By News Bureau
Interviews
Arpit Bhatia, Director, Laborate Pharmaceuticals
As India’s pharmaceutical sector shifts from volume-driven growth to global-grade quality and compliance, Arpit Bhatia, Director, Laborate Pharmaceuticals, discusses evolving manufacturing standards, regulator...
Dr. Supriya Shidhaye, Principal, Vivekanand Education Society's College of Pharmacy
As pharmaceutical manufacturing evolves into a technology-driven and globally integrated sector, academic institutions must align closely with industry expectations to build future-ready talent, said Dr. Supriya Shi...
Shivani Wagh, Joint MD, Supriya Lifescience
On the eve of Women’s Day, Shivani Wagh, Joint MD, Supriya Lifescience, speaks to Pharma Industrial India about leadership, global expansion, building inclusive teams, and advancing opportunities for women in ...
Articles
How Expanding Access to Chelation Therapy Is Reshaping Wilson?s Disease Management in India
India’s rare disease landscape is shifting from innovation to access, with improved availability of chelation therapies like Trientine highlighting how regulatory pathways, industry efforts and evolving clinic...
The Invisible Risk in Cleanrooms
Why must personnel apparel be taken seriously? Using Personal Protective Equipment (PPE) is one of the most important contamination control decisions in pharmaceutical manufacturing....
Why Manufacturing Discipline is Becoming a True Differentiator in Generic Pharmaceuticals
Discipline has become the real competitive advantage in generic pharmaceuticals, overtaking scale, speed and low cost as the main drivers of success....
Blog
Building a Resilient Pharma Supply Chain in India: Challenges, Innovations and the Road Ahead
By Darshana Daga
PRIP Scheme Set for Rollout: Key Highlights of the INR 5,000 Cr Initiative
By Pharma Industrial India
Latest news in...
Ingredients
- - Seasonal Flu Vaccines to Target Three Strains in 2026-27: EMA Guidance
- - Mankind Pharma Acquires Rivotril Brand for India, Reinforcing Focus on Chronic CNS Therapies
- - Andera Partners Targets EUR 10 Billion AUM as It Accelerates Innovation and European Expansion
- - US Food and Drug Administration to Drop Two-Study Requirement for New Drug Approvals
Next events
Appointments
Saumen Chakraborty, Member Board of Directors, PREMAS BIOTECH
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Silvia Steyrer-Grube, Chief Executive Officer, CEO, Coriolis Pharma
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy